Umkhiqizo Wokuthengisa Okushisayo
Ngemibuzo mayelana nemikhiqizo yethu noma uhlu lwamanani, sicela usishiyele i-imeyili futhi sizokuthinta kungakapheli amahora angama-24.
Izindaba
-
Isingeniso Sokuxilonga Okusheshayo Kokugeleza Kwe-Lateral
Izibonakhulu ezikhanyayo ezivela ku-Leica Microsystems zihlangabezana nezidingo eziphakeme kakhulu kunoma yisiphi isicelo - kusukela emsebenzini ojwayelekile waselabhorethri kuya ocwaningweni lwezinqubo eziguquguqukayo ezinezinhlangothi eziningi kumaseli aphilayo. -
Ukuzihlola ngokuhlolwa kwe-antigen njengendlela yokunciphisa i-SARS-CoV-2
Kubhubhane lwe-COVID-19, ukuhlinzekwa kokunakekelwa kwezempilo okwanele ezigulini kubalulekile ukuze kugcinwe ukufa kuphansi.Izinto zezokwelapha, ikakhulukazi abasebenzi bezimo eziphuthumayo, abamele umugqa wokuqala wokulwa ne-COVID-19 [1].Kusesimisweni sangaphambi kwesibhedlela lapho isiguli ngasinye kufanele siphathwe njengesiguli esingase sibe nezifo, futhi kwadalula ikakhulukazi izinto zezokwelapha ezisebenza phambili engcupheni yokutheleleka nge-SARS-CoV-2 [2]. -
Ukusetshenziswa kokuhlolwa okusheshayo kwe-COVID-19 antigen kuwo wonke amazwe ase-Europe
Kusukela ngoMashi ekuqaleni kwalo nyaka, iningi lethu belihlala lilodwa ngandlela thize, lihlala bodwa, futhi ngokungafani nanini ngaphambili.I-COVID-19, okuwuchungechunge lwe-coronavirus, ubhubhane lomhlaba wonke oluthinta amazwe anjenge-Italy, i-United Kingdom, i-United States, iSpain neChina, phakathi kwamanye.
Mayelana ne-Himedic Biotech
Nakekela Impilo Yakho
I-Hangzhou Himedic Biotech Co., Ltd ingumkhiqizi ochwepheshile ocwaningweni, ekuthuthukisweni nasekukhiqizweni kwezinsiza zokuhlola zokuxilonga ze-In vitro, i-POCT kanye nezinto eziphilayo.Njengamanje, inkampani inamamitha-skwele ayi-1,800 we-R&D kanye nesisekelo sokukhiqiza esiqukethe izinga elithuthukile lemigqa yokukhiqiza yama-colloidal diagnostic reagents enamandla okukhiqiza wonyaka amashumi ezigidi zokuhlolwa.